Gracell Biotechnologies to Report Second Quarter 2022 Financial on Monday, August 15, 2022

Rhea-AI Summary

Gracell Biotechnologies Inc. (NASDAQ: GRCL) will announce its unaudited financial results for Q2 2022, ending June 30, on August 15, 2022, before U.S. markets open. The company, focused on creating affordable cell therapies for cancer treatment, will provide a business update during a live audio webcast and conference call at 8:00 AM ET. Investors can join via domestic and international dial-ins, and a replay will be available for 90 days post-event. For more details, visit Gracell's website.

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 2, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it plans to release unaudited financial results for the second quarter ended June 30, 2022 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, August 15, 2022. The management team will host a live audio webcast and conference call at 8:00 AM Eastern Time.

Conference call and webcast details:

Monday, August 15, 2022 @ 8:00am ET
Investor domestic dial-in: (800) 715-9871
Investor international dial-in: (646) 307-1963
Conference ID: 7693510

Live webcast link: https://ir.gracellbio.com/news-events/events-and-presentations

A replay of the webcast will be available on ir.gracellbio.com shortly after the conclusion of the event for 90 days.

About Gracell
Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART^TM technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com. Follow @GracellBio on LinkedIn.

Media contacts
Marvin Tang
marvin.tang@gracellbio.com

Kyle Evans
kyle.evans@westwicke.com

Investor contacts
Gracie Tong
gracie.tong@gracellbio.com
Stephanie Carrington
stephanie.carrington@westwicke.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-report-second-quarter-2022-financial-on-monday-august-15-2022-301597765.html

SOURCE Gracell Biotechnologies Inc.

FAQ

When will Gracell report its Q2 2022 financial results?

Gracell will report its Q2 2022 financial results on August 15, 2022.

What time is Gracell's Q2 2022 earnings call?

The earnings call is scheduled for 8:00 AM ET on August 15, 2022.

How can I listen to Gracell's Q2 2022 earnings call?

You can listen to the earnings call by dialing (800) 715-9871 for domestic or (646) 307-1963 for international investors.

Where can I find Gracell's Q2 2022 financial results?

Gracell's Q2 2022 financial results will be available on their website following the earnings call.

What is the purpose of Gracell's earnings call on August 15, 2022?

The earnings call will provide an update on Gracell's recent developments and financial results for Q2 2022.